The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
The future challenges facing the development of new antimicrobial drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Lewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980
Fleming, A. (1929) · PubMed Central · Cited by 1,647
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Gold, H. S., & Moellering, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351907 · Cited by 1,070
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
How many antibiotics are produced by the genus Streptomyces ?
Watve, M., Tickoo, R., Jog, M., & Bhole, B. (2001) · Archives of Microbiology · doi:10.1007/s002030100345 · Cited by 923
Cited by
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Microbial drug discovery: 80 years of progress
Demain, A. L., & Sanchez, S. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2008.16 · Cited by 1,002
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005) · Chemical Reviews · doi:10.1021/cr030102i · Cited by 913
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Where will new antibiotics come from?
Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755
Antimicrobial silver nanomaterials
Zheng, K., Setyawati, M. I., Leong, D. T., & Xie, J. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.11.019 · Cited by 703
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 672
Novel classes of antibiotics or more of the same?
Coates, A. R., Halls, G., & Hu, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01250.x · Cited by 598
Self-citationNanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes
Rudramurthy, G., Swamy, M., Sinniah, U., & Ghasemzadeh, A. (2016) · Molecules · doi:10.3390/molecules21070836 · Cited by 556
In Vitro Antimicrobial Activity of Some Medicinal Plants against Human Pathogenic Bacteria
Manandhar, S., Luitel, S., & Dahal, R. K. (2019) · Journal of Tropical Medicine · doi:10.1155/2019/1895340 · Cited by 525
Menichetti, A., Mavridi-Printezi, A., Mordini, D., & Montalti, M. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14050244 · Cited by 502
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Recent applications of multicomponent reactions in medicinal chemistry
Slobbe, P., Ruijter, E., & Orru, R. V. A. (2012) · MedChemComm · doi:10.1039/c2md20089a · Cited by 484
Zhang, Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg446 · Cited by 477
Combating Multidrug‐Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
O'Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209979 · Cited by 435
Khan, R., Islam, B., Akram, M., Shakil, S., Ahmad, A. A., Ali, S. M., Siddiqui, M., & Khan, A. U. (2009) · Molecules · doi:10.3390/molecules14020586 · Cited by 420
Nathan, C. (2004) · Nature · doi:10.1038/431899a · Cited by 410
Mulyaningsih, S., Sporer, F., Zimmermann, S., Reichling, J., & Wink, M. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.06.018 · Cited by 393
Antimicrobial peptides of the genus Bacillus: a new era for antibiotics
Sumi, C. D., Yang, B. W., Yeo, I.-C., & Hahm, Y. T. (2015) · Canadian Journal of Microbiology · doi:10.1139/cjm-2014-0613 · Cited by 379
Natural products — The future scaffolds for novel antibiotics?
Butler, M. S., & Buss, A. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.012 · Cited by 337
Strategies to overcome resistance to targeted protein kinase inhibitors
Daub, H., Specht, K., & Ullrich, A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1579 · Cited by 334
Dhingra, S., Rahman, N. A. A., Peile, E., Rahman, M., Sartelli, M., Hassali, M. A., Islam, T., Islam, S., & Haque, M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.535668 · Cited by 329
Evolution of the serine β-lactamases: past, present and future
Hall, B. G., & Barlow, M. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.02.003 · Cited by 314
Cho, S. H., Warit, S., Wan, B., Hwang, C. H., Pauli, G. F., & Franzblau, S. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00055-06 · Cited by 292
Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic Development
YONEYAMA, H., & KATSUMATA, R. (2006) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.70.1060 · Cited by 286
Virtual drug discovery and development for neglected diseases through public–private partnerships
Nwaka, S., & Ridley, R. G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1230 · Cited by 260
Annunziato, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235844 · Cited by 256
Antibiotic adjuvants – A strategy to unlock bacterial resistance to antibiotics
González-Bello, C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.027 · Cited by 254
Inhibitors of FabI, an Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway
Lu, H., & Tonge, P. J. (2008) · Accounts of Chemical Research · doi:10.1021/ar700156e · Cited by 254
Antimicrobial Activity and Protease Stability of Peptides Containing Fluorinated Amino Acids
Meng, H., & Kumar, K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075373f · Cited by 252
Bhadury, P., Mohammad, B. T., & Wright, P. C. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-005-0070-3 · Cited by 250
Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics
Defraine, V., Fauvart, M., & Michiels, J. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.002 · Cited by 222
Carpenter, A. W., Worley, B. V., Slomberg, D. L., & Schoenfisch, M. H. (2012) · Biomacromolecules · doi:10.1021/bm301108x · Cited by 132
Assessment of anti-quorum sensing activity for some ornamental and medicinal plants native to Egypt
Zaki, A. A. (2013) · Scientia Pharmaceutica · doi:10.3797/scipharm.1204-26 · Cited by 53
Metadata
- Authors
- Coates, A., Hu, Y., Bax, R., & Page, C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-11
- Volume
- 1
- Issue
- 11
- Pages
- 895-910
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2053696392
- Cited by
- 704
- References
- 110
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.